Publication:
Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: Comparison of retroperitoneoscopic and open nephroureterectomy

dc.contributor.authorTawatchai Taweemonkongsapen_US
dc.contributor.authorChaiyong Nualyongen_US
dc.contributor.authorTeerapon Amornvesukiten_US
dc.contributor.authorSunai Leewansangtongen_US
dc.contributor.authorSittiporn Srinualnaden_US
dc.contributor.authorBansithi Chaiyaprasithien_US
dc.contributor.authorPhichaya Sujijantararaten_US
dc.contributor.authorAnupan Tantiwongen_US
dc.contributor.authorSuchai Soontrapaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-12T02:46:54Z
dc.date.available2018-07-12T02:46:54Z
dc.date.issued2008-01-15en_US
dc.description.abstractObjectives: To determine the surgical and oncologic outcomes in patients who underwent retroperitoneoscopic nephroureterectomy (RNU) in comparison to standard open nephroureterectomy (ONU) for upper urinary tract transitional cell carcinoma (TCC). Patients and methods: From April 2001 to January 2007, 60 total nephroureterectomy were performed for upper tract TCC at Siriraj Hospital. Of the 60 patients, thirty-one were treated with RNU and open bladder cuff excision, and twenty-nine with ONU. Our data were reviewed and analyzed retrospectively. The recorded data included sex, age, history of bladder cancer, type of surgery, tumor characteristics, postoperative course, disease recurrence and progression. Results: The mean operative time was longer in the RNU group than in the ONU group (258.8 versus 190.6 min; p = 0. < 001). On the other hand, the mean blood loss and the dose of parenteral analgesia (morphine sulphate) were lower in the RNU group (289.3 versus 313.7 ml and 2.05 versus 6.72 mg; p = 0.868 and p = 0.018, respectively). There were two complications in each group. No significant difference in p stage and grade in both-groups (p = 0.951, p = 0.077). One patient with RNU had lymph node involvement, three in ONU. Mean follow up was 26.4 months (range 3-72) for RNU and 27.9 months (range 3-63) for ONU. No port metastasis occurred during follow up in RNU group. Tumor recurrence developed in 11 patients (bladder recurrence in 9 patients, local recurrence in 2 patients) in the RNU group and 14 patients (bladder recurrence in 13 patients, local recurrence in 1 patient) in the ONU group. No significant difference was detected in the tumor recurrence rate between the two procedures (p = 0.2716). Distant metastases developed in 3 patients (9.7%) after RNU and 2 patients (6.9%) after ONU. The 2 year disease specific survival rate after RNU and ONU was 86.3% and 92.5%, respectively (p = 0.8227). Conclusion: Retroperitoneoscopic nephroureterectomy is less invasive than open surgery and is an oncological feasible operation. Thus, the results of our study supported the continued development of laparoscopic technique in the management of upper tract TCC. © 2008 Taweemonkongsap et al; licensee BioMed Central Ltd.en_US
dc.identifier.citationWorld Journal of Surgical Oncology. Vol.6, (2008)en_US
dc.identifier.doi10.1186/1477-7819-6-3en_US
dc.identifier.issn14777819en_US
dc.identifier.other2-s2.0-40949146573en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/19781
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=40949146573&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleOutcomes of surgical treatment for upper urinary tract transitional cell carcinoma: Comparison of retroperitoneoscopic and open nephroureterectomyen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=40949146573&origin=inwarden_US

Files

Collections